Target intelligence / Profile preview

Ankyrin repeat and sterile alpha motif domain-containing protein 3 (ANKS3)

Target
ANKS3
Molecular classification
Other (complex scaffold/signaling protein with ankyrin repeats and SAM domain)
01

Overview

ANKS3 encodes a scaffold protein characterized by ankyrin repeats and a sterile alpha motif (SAM) domain. This protein is predicted to function in the cytoplasm, localizing to cilia and potentially regulating cell polarity and ciliary movement. It is involved in complex formation with other nephronophthisis (NPH) proteins—such as ANKS6/NPHP16, Bicc1, and HIF1AN—and is essential for kidney development, functionality, and left–right patterning. Depletion or mutation of ANKS3 disrupts central metabolic pathways and nucleoside balance, leading to DNA damage responses and cell viability reduction; mutations in ANKS3 are causative of nephronophthisis and related ciliopathies as well as laterality defects in humans. While ANKS3 is not yet a direct drug target, it is a critical node in protein interaction networks underlying important developmental processes and diseases.

Other names
ANKS3NPHP16
02

Biological functions

Protein–protein interaction scaffoldRegulation of ciliary function/polarityRegulation of cellular metabolism (including glycolysis, TCA cycle, amino acid and nucleotide metabolism)DNA damage responseModulation of intracellular signaling cascades (notably negative regulation of canonical Wnt signaling via Bicc1 interaction)
03

Disease associations

Ciliopathy/nephronophthisis (NPH)Visceral heterotaxyLaterality defects (developmental)Potential links to mitochondrial and metabolism-related pathology
04

Safety considerations

Loss of function results in significant cell viability reduction and developmental/organ dysfunctionPotential issues of metabolic derangements if targeted
05

Biomarkers

ANKS3 mutation (genetic biomarker for nephronophthisis or laterality disorders)

Beyond the preview

Go deeper on Ankyrin repeat and sterile alpha motif domain-containing protein 3 (ANKS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and sterile alpha motif domain-containing protein 3 (ANKS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call